Analytical and Clinical Validation of a Prostate Cancer-Enhanced messenger RNA Detection Assay in Whole Blood as a Prognostic Biomarker for Survival

BACKGROUND: Biomarkers based on detecting prostate cancer-specific transcripts are associated with inferior outcomes, but their validation in a clinical context is lacking. OBJECTIVE: To determine whether detecting prostate cancer enhanced transcripts in whole blood using an analytically valid assay...

Celý popis

Uloženo v:
Podrobná bibliografie
Hlavní autoři: Danila, Daniel C., Anand, Aseem, Schultz, Nikolaus, Heller, Glenn, Wan, Mingliang, Sung, Clifford C., Dai, Charles, Khanin, Raya, Fleisher, Martin, Lilja, Hans, Scher, Howard I.
Médium: Artigo
Jazyk:Inglês
Vydáno: 2013
Témata:
Article
On-line přístup:https://ncbi.nlm.nih.gov/pmc/articles/PMC4113474/
https://ncbi.nlm.nih.gov/pubmed/23954088
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.eururo.2013.07.006
Tagy: Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!

Podobné jednotky